What is CNFRZ's earnings per share (EPS)?

CNFRZ (CNFRZ) reported diluted earnings per share of $-1.51 for fiscal year 2025. This represents a -178.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CNFRZ Financials

CNFRZ

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows CNFRZ (CNFRZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNFRZ FY2025 2026-04-22

A shrinking revenue base and sticky operating costs are overwhelming earnings and leaving little balance-sheet cushion.

The clearest signal is the disconnect between earnings and cash: FY2024 showed $24.3M of net income even as operating cash flow was -$32.7M and operating margin was -55.4%, then FY2025 flipped back to a -$18.4M net loss while cash burn widened to -$43.9M. That makes the FY2024 profit look like a non-operating accounting swing, not evidence that the core business had become self-funding.

Across FY2023-FY2025, revenue contraction from $90.5M to $43.3M came with operating margin worsening from -33.7% to -59.8%. That pattern points to a cost structure that does not shrink easily, so lower activity is making losses proportionally larger rather than merely smaller in dollars.

The balance sheet looks less constrained by term debt than by cash consumption and a thin equity cushion: cash of $27.4M was above long-term debt of $12.2M, but liabilities of $230.3M left only $9.0M of equity. In practice, the business is being financed by liabilities while operations are not yet replenishing cash.

Financial Health Signals

Financial health score pending refresh

We are recalculating CNFRZ's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

1/7

CNFRZ passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

2.38x

For every $1 of reported earnings, CNFRZ generates $2.38 in operating cash flow (-$43.9M OCF vs -$18.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-8.1x

CNFRZ earns $-8.1 in operating income for every $1 of interest expense (-$25.9M vs $3.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$43.3M

YoY-35.6%

5Y CAGR-16.0%

10Y CAGR-4.8%

CNFRZ generated $43.3M in revenue in fiscal year 2025. This represents a decrease of 35.6% from the prior year.

EBITDA

N/A

Net Income

-$18.4M

YoY-175.7%

CNFRZ reported -$18.4M in net income in fiscal year 2025. This represents a decrease of 175.7% from the prior year.

EPS (Diluted)

$-1.51

YoY-178.2%

CNFRZ earned $-1.51 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 178.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$27.4M

YoY-1.1%

5Y CAGR+27.3%

10Y CAGR+8.0%

CNFRZ held $27.4M in cash against $12.2M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

12M

YoY+0.0%

5Y CAGR+4.8%

10Y CAGR+4.8%

CNFRZ had 12M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-59.8%

YoY-4.4pp

5Y CAGR-51.0pp

CNFRZ's operating margin was -59.8% in fiscal year 2025, reflecting core business profitability. This is down 4.4 percentage points from the prior year.

Net Margin

-42.6%

YoY-78.8pp

5Y CAGR-43.1pp

10Y CAGR-42.7pp

CNFRZ's net profit margin was -42.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 78.8 percentage points from the prior year.

Return on Equity

-205.6%

YoY-318.8pp

5Y CAGR-207.0pp

10Y CAGR-205.7pp

CNFRZ's ROE was -205.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 318.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CNFRZ Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$43.3M-35.6%	$67.3M-25.7%	$90.5M-13.7%	$104.9M-9.5%	$116.0M+12.1%	$103.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$25.9M+30.6%	-$37.3M-22.4%	-$30.5M-7.5%	-$28.3M-112.2%	-$13.3M-47.0%	-$9.1M
Interest Expense	$3.2M-34.8%	$4.9M+52.3%	$3.2M+7.9%	$3.0M+4.2%	$2.9M-2.5%	$2.9M
Income Tax	$141K+107.7%	-$1.8M-421.2%	-$353K+96.3%	-$9.4M-4638.9%	$208K+3366.7%	$6K
Net Income	-$18.4M-175.7%	$24.3M+193.9%	-$25.9M-142.7%	-$10.7M-876.3%	-$1.1M-283.9%	$595K
EPS (Diluted)	$-1.51-178.2%	$1.93+191.0%	$-2.12-112.0%	$-1.00-809.1%	$-0.11-283.3%	$0.06

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$11.5M+150.2%	$4.6M-30.9%	$6.7M-58.6%	$16.1M+1.6%	$15.9M+7.8%	$14.7M-8.1%	$16.0M-10.5%	$17.9M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$1.1M+92.9%	-$14.9M-411.2%	-$2.9M+20.1%	-$3.6M+17.8%	-$4.4M+83.0%	-$26.1M-255.7%	-$7.3M-68.5%	-$4.4M
Interest Expense	$2.0M+118.1%	$906K+3.7%	$874K+1.2%	$864K+59.7%	$541K-37.3%	$863K-62.1%	$2.3M+162.1%	$868K
Income Tax	-$38K-127.0%	$141K	$0	$0	$0-100.0%	$11K+100.8%	-$1.4M-310.5%	-$333K
Net Income	$2.6M+115.4%	-$17.0M-329.2%	-$4.0M-293.6%	$2.1M+292.9%	$522K+102.1%	-$24.6M-146.5%	$52.8M+1436.4%	-$4.0M
EPS (Diluted)	$0.15	N/A	$-0.32-288.2%	$0.17+325.0%	$0.04	N/A	$4.32+1450.0%	$-0.32

CNFRZ Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$239.3M-15.0%	$281.7M-10.8%	$315.6M+1.0%	$312.4M+7.6%	$290.4M+11.0%	$261.6M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$27.4M-1.1%	$27.7M+159.3%	$10.7M-62.0%	$28.0M+182.8%	$9.9M+21.0%	$8.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$230.3M-11.5%	$260.1M-16.8%	$312.7M+6.6%	$293.4M+17.4%	$249.9M+15.1%	$217.2M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$12.2M+2.1%	$11.9M-52.4%	$25.1M-26.0%	$33.9M+0.9%	$33.6M-18.1%	$41.0M
Total Equity	$9.0M-58.3%	$21.5M+645.1%	$2.9M-84.8%	$18.9M-53.2%	$40.5M-8.8%	$44.4M
Retained Earnings	-$81.6M-29.2%	-$63.2M+27.1%	-$86.7M-42.7%	-$60.8M-21.3%	-$50.1M-2.2%	-$49.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$236.6M-1.1%	$239.3M-16.0%	$285.0M+0.6%	$283.3M+2.2%	$277.1M-1.6%	$281.7M-6.1%	$299.9M+2.4%	$292.9M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$25.5M-6.9%	$27.4M+269.1%	$7.4M-66.2%	$22.0M+113.5%	$10.3M-62.8%	$27.7M-14.6%	$32.4M+234.0%	$9.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$211.4M-8.2%	$230.3M-11.3%	$259.7M+1.8%	$255.1M+1.4%	$251.5M-3.3%	$260.1M+3.7%	$250.8M-14.7%	$294.1M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$12.3M+0.5%	$12.2M+0.5%	$12.1M+0.5%	$12.1M+0.5%	$12.0M+0.5%	$11.9M-27.6%	$16.5M-33.7%	$24.8M
Total Equity	$25.2M+181.0%	$9.0M-64.6%	$25.3M-10.3%	$28.2M+10.3%	$25.6M+18.9%	$21.5M-56.1%	$49.1M+4310.4%	-$1.2M
Retained Earnings	-$79.0M+3.2%	-$81.6M-26.4%	-$64.5M-6.6%	-$60.6M+3.3%	-$62.6M+0.8%	-$63.2M-67.2%	-$37.8M+58.3%	-$90.6M

CNFRZ Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$43.9M-34.3%	-$32.7M-144.0%	-$13.4M+66.9%	-$40.5M-855.8%	$5.4M+79.6%	$3.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$78K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	$2.9M
Investing Cash Flow	N/A	N/A	-$272K-100.5%	$56.5M+4003.3%	$1.4M+118.8%	-$7.3M
Financing Cash Flow	$15.5M+173.5%	-$21.1M-549.6%	-$3.2M-255.1%	$2.1M+141.8%	-$5.0M-198.6%	$5.1M
Dividends Paid	$0	$0	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	$12K-66.7%	$36K

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$8.3M+67.0%	-$25.2M-3598.2%	-$681K+75.3%	-$2.8M+81.9%	-$15.3M+23.7%	-$20.0M-86.5%	-$10.7M-5.9%	-$10.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$168K	N/A	-$13.9M-196.0%	$14.4M+250.1%	-$9.6M	N/A	$49.2M+1586.2%	$2.9M
Financing Cash Flow	$6.2M-21.9%	$8.0M	$0	$0-100.0%	$7.5M+266.7%	-$4.5M+71.4%	-$15.8M-3760.8%	-$408K
Dividends Paid	$0	$0	$0	$0	$0	$0	$0+100.0%	-$176K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CNFRZ Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-59.8%-4.4pp	-55.4%-21.8pp	-33.7%-6.6pp	-27.0%-15.5pp	-11.5%-2.7pp	-8.8%
Net Margin	-42.6%-78.8pp	36.2%+64.8pp	-28.6%-18.5pp	-10.2%-9.2pp	-0.9%-1.5pp	0.6%
Return on Equity	-205.6%-318.8pp	113.1%+1010.4pp	-897.3%-840.9pp	-56.4%-53.7pp	-2.7%-4.0pp	1.3%
Return on Assets	-7.7%-16.4pp	8.6%+16.9pp	-8.2%-4.8pp	-3.4%-3.0pp	-0.4%-0.6pp	0.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.36+0.8	0.55-8.1	8.67+6.9	1.79+1.0	0.83-0.1	0.92
FCF Margin	N/A	N/A	N/A	N/A	N/A	2.8%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-9.2%+313.5pp	-322.7%-279.1pp	-43.6%-21.0pp	-22.6%+5.3pp	-27.9%+149.2pp	-177.1%-131.4pp	-45.8%-21.5pp	-24.3%
Net Margin	22.7%+391.9pp	-369.2%-309.7pp	-59.4%-72.2pp	12.7%+9.4pp	3.3%+170.1pp	-166.8%-496.4pp	329.6%+351.6pp	-22.1%
Return on Equity	10.4%+200.5pp	-190.1%-174.4pp	-15.7%-23.0pp	7.3%+5.2pp	2.0%+116.2pp	-114.1%-221.7pp	107.6%	N/A
Return on Assets	1.1%+8.2pp	-7.1%-5.7pp	-1.4%-2.1pp	0.7%+0.5pp	0.2%+8.9pp	-8.7%-26.3pp	17.6%+18.9pp	-1.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.49-0.9	1.36+0.9	0.48+0.1	0.43-0.0	0.47-0.1	0.55+0.2	0.34	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is CNFRZ's annual revenue?

CNFRZ (CNFRZ) reported $43.3M in total revenue for fiscal year 2025. This represents a -35.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CNFRZ's revenue growing?

CNFRZ (CNFRZ) revenue declined by 35.6% year-over-year, from $67.3M to $43.3M in fiscal year 2025.

Is CNFRZ profitable?

No, CNFRZ (CNFRZ) reported a net income of -$18.4M in fiscal year 2025, with a net profit margin of -42.6%.

How much debt does CNFRZ have?

As of fiscal year 2025, CNFRZ (CNFRZ) had $27.4M in cash and equivalents against $12.2M in long-term debt.

What is CNFRZ's operating margin?

CNFRZ (CNFRZ) had an operating margin of -59.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CNFRZ's net profit margin?

CNFRZ (CNFRZ) had a net profit margin of -42.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CNFRZ's return on equity (ROE)?

CNFRZ (CNFRZ) has a return on equity of -205.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CNFRZ's operating cash flow?

CNFRZ (CNFRZ) generated -$43.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CNFRZ's total assets?

CNFRZ (CNFRZ) had $239.3M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does CNFRZ have outstanding?

CNFRZ (CNFRZ) had 12M shares outstanding as of fiscal year 2025.

What is CNFRZ's debt-to-equity ratio?

CNFRZ (CNFRZ) had a debt-to-equity ratio of 1.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CNFRZ's return on assets (ROA)?

CNFRZ (CNFRZ) had a return on assets of -7.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CNFRZ's cash runway?

Based on fiscal year 2025 data, CNFRZ (CNFRZ) had $27.4M in cash against an annual operating cash burn of $43.9M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is CNFRZ's Piotroski F-Score?

CNFRZ (CNFRZ) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CNFRZ's earnings high quality?

CNFRZ (CNFRZ) has an earnings quality ratio of 2.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CNFRZ cover its interest payments?

CNFRZ (CNFRZ) has an interest coverage ratio of -8.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.